The US Court of Appeals for the Federal Circuit affirmed the Patent Trial & Appeal Board’s determination that 79 challenged composition claims across three related patents were unpatentable but ...
The AVIPure dsRNA Clear resin launch follows last week’s formal completion by Repligen of its acquisition of Tantti Laboratory Inc., announced on July 29, 2024.
The downstream processing market is expanding rapidly, driven by rising biopharmaceutical demand and innovations in purification technologies like chromatography and single-use systems.Austin, Dec. 08 ...